The Life Cycle of Health Technologies. Challenges and Ways Forward

Front Pharmacol. 2017 Jan 24:8:14. doi: 10.3389/fphar.2017.00014. eCollection 2017.

¹ Osteba, Basque Office for Health Technology Assessment (HTA), Ministry for Health, Basque Government Vitoria-Gasteiz, Spain.
² Societá Italiana di Farmacia Clinica e Terapia (SIFaCT) - Italian Society of Clinical Pharmacy and Therapeutics Milan, Italy.
³ German Agency for Health Technology Assessment (DAHTA), Deutsches Institut für Medizinische Dokumentation und Information (DIMDI) Cologne, Germany.

No abstract available

Keywords: disinvestment; health technology assessment; innovation; investment; life cycle assessment; real world data; reimbursement mechanisms.